Anlageziel Private Suite - PICTET Health Innovation Trends G EUR Acc Fonds

The Sub-fund, expressed in Euro, aims to achieve long-term capital growth by investing primarily in equity securities issued by bio-pharmaceutical companies throughout the world (including emerging countries). However, in light of the particularly innovative nature of the pharmaceutical industry in North America and Western Europe, the vast majority of investments in equity securities issued by bio-pharmaceutical companies will be made in these regions. The Sub-fund may also invest in equities or equity related securities issued by companies that are active in sectors related to health.